Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Effect of ARC1779 Injection on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy

NCT00742612 is registered in ClinicalTrials.gov with Archemix Corp. as lead sponsor.

NCT NCT00742612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00742612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Effect of ARC1779 Injection on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy
Lead sponsor
Archemix Corp.
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2009
Completion date
April 30, 2010
Enrollment
100 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

carotid stenosis, cerebral thromboembolism, intracranial embolism